TB-500 vs Thymosin Beta-4 — Fragment vs Full Protein
TB-500 and Thymosin Beta-4 are searched as if they're two compounds to choose between — but they're not rivals. TB-500 is the synthetic active fragment of the naturally occurring Thymosin Beta-4 (Tβ4) protein. This page explains the real relationship, the genuine differences, and what it means in practice.
Thymosin Beta-4 (Tβ4): the full, naturally occurring 43-amino-acid protein — the parent molecule.
TB-500: the synthetic active fragment of Tβ4 — shorter, easier to make, and the form nearly all vendors actually sell.
Bottom line up front: same active molecule family, not a “which is better” contest — the practical differences are length, sourcing, and cost.
Why people think these are two different compounds
Vendors and forums use “TB-500” and “Thymosin Beta-4” as if they were competing products, so people assume they must pick one. In reality, Thymosin Beta-4 is a 43-amino-acid protein your cells already make, and TB-500 is a lab-synthesized fragment of it — specifically the active region (often described as the Tβ4 17-23 region) that carries the actin-binding and cell-migration activity.
The fragment became the standard research-peptide form for a practical reason: it is far easier and cheaper to synthesize than the full-length protein while retaining the part responsible for the repair effects. So most material sold as “TB-500” — and much of what is loosely labeled “Thymosin Beta-4” — is the same synthetic fragment, commonly supplied as an acetate salt.
Because they share the same active region, they share the same core mechanism. Framing them as a head-to-head efficacy contest is misleading; the honest comparison is fragment vs full protein, and what that means for sourcing, cost, and what you actually receive.
| Thymosin Beta-4 (full protein) | TB-500 (fragment) | |
|---|---|---|
| What it is | Naturally occurring 43-amino-acid protein found in nearly all mammalian cells | Synthetic active fragment of Thymosin Beta-4 (the Tβ4 17-23 region) — the form most vendors sell |
| Structure | Full 43-aa peptide (encoded by the TMSB4X gene) | Short synthetic fragment, usually supplied as an acetate salt |
| Active region | Contains the actin-binding / cell-migration active site (plus the rest of the protein) | Retains that actin-binding active region — the part responsible for the repair activity |
| Mechanism | Actin sequestration → cell migration, angiogenesis, anti-inflammatory (M1→M2 macrophage shift), wound healing | Same active region → the same core mechanism as the parent protein |
| Sourcing | Endogenous; full-length recombinant/synthetic protein is rarer and costlier as a research material | Lab-synthesized; widely sold as a research peptide labeled “TB-500” |
| Research context | Named human trials exist (e.g. RegeneRx Phase 2 corneal / dry-eye programs) | “TB-500” is largely the research-peptide and animal-model label; its evidence overlaps the Tβ4 literature |
| What you actually receive | Vials labeled “Thymosin Beta-4” may be the full protein, but the term is often used loosely | Vials labeled “TB-500” are the synthetic fragment — check the COA and stated sequence |
| FDA status | Not FDA-approved | Not FDA-approved |
| Human evidence | Limited — mostly preclinical, plus early-phase trials | Limited — mostly preclinical / animal models |
Which one is right for you?
Both are research-use-only and neither is FDA-approved. Since they share the same active region, the choice is practical rather than an efficacy question.
Most research use — the fragment (TB-500)
For the overwhelming majority of tissue-repair research questions, TB-500 is the default. It carries the active actin-binding region, it is what nearly every vendor stocks, and it is cheaper and more consistently available than the full-length protein. If a protocol just calls for “Thymosin Beta-4 activity,” the fragment is what is typically used.
When the full-length protein specifically matters
Some research questions target properties of the complete 43-amino-acid protein (for example, regions outside the core active fragment, or work aligned with the named Thymosin Beta-4 clinical programs). In those cases full-length Tβ4 is the correct material — expect it to be rarer and more expensive, and verify the sequence/length on the Certificate of Analysis.
Verify what you are actually buying
Because the labels are used loosely, the most important step is checking the COA. A vial labeled “Thymosin Beta-4” is not guaranteed to be the full protein, and “TB-500” is the fragment. Confirm the stated amino-acid sequence/length and salt form so the material matches your protocol.
Bottom Line
TB-500 and Thymosin Beta-4 are not competing compounds — TB-500 is the synthetic active fragment of the full 43-amino-acid Thymosin Beta-4 protein, and it is the form nearly all vendors sell. They share the same active region and the same core mechanism, so this is a fragment-vs-full-protein distinction, not a which-is-better contest. Most research uses the fragment; full-length Tβ4 is reserved for questions that specifically require the complete protein. Neither is FDA-approved, the evidence base is largely preclinical, and both are sold research-use-only — always verify the sequence on the Certificate of Analysis. Commonly stacked with BPC-157 in the Wolverine Stack.
FAQ
Is TB-500 the same as Thymosin Beta-4?
Not exactly — TB-500 is a synthetic fragment of the full Thymosin Beta-4 protein. The fragment retains the active region responsible for cell migration and wound healing but is shorter (and easier to synthesize) than the 43-amino-acid full protein. Most research literature uses the terms interchangeably, though strict pharmacology references distinguish them.
Is TB-500 just a fragment of TB4?
Yes. TB-500 corresponds to the active region of Thymosin Beta-4 (commonly described as the Tβ4 17-23 region) — the part that drives actin binding, cellular migration, and wound-healing activity. It is easier and cheaper to synthesize than the full 43-amino-acid protein, which is why it became the standard research-peptide form.
Which should I choose — TB-500 or Thymosin Beta-4?
For most research purposes they represent the same active molecule, so this isn't a which-is-better contest. In practice, nearly every vendor sells the TB-500 fragment (often as the acetate salt); full-length Thymosin Beta-4 is rarer and more expensive. Choose full-length only if your protocol specifically requires the complete protein — otherwise TB-500 is the default.
Is Thymosin Beta-4 FDA-approved?
No. Neither the full Thymosin Beta-4 protein nor the TB-500 fragment is FDA-approved. Thymosin Beta-4 reached Phase 2 human trials (notably RegeneRx's corneal and dry-eye programs), but no product has been approved, and most of the evidence base is preclinical. Both are sold research-use-only.
What do I actually receive when I order "Thymosin Beta-4" vs "TB-500"?
Usually the same synthetic fragment. Vials labeled “TB-500” are the fragment (frequently the acetate salt). “Thymosin Beta-4” can denote the full-length protein but is often used loosely for the same fragment. Check the Certificate of Analysis and the stated sequence/length to confirm exactly what you are getting.
References
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. https://pubmed.ncbi.nlm.nih.gov/22074294/
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. https://pubmed.ncbi.nlm.nih.gov/10469335/
- Smart N, Risebro CA, Melville AA, et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature. 2007;445(7124):177-182. https://pubmed.ncbi.nlm.nih.gov/17108969/
- Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin beta4 and corneal wound healing: visions of the future. Ann N Y Acad Sci. 2010;1194:190-198. https://pubmed.ncbi.nlm.nih.gov/20536468/
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. 2025 (review; notes TB-500/Tβ4 human clinical evidence remains limited). https://pmc.ncbi.nlm.nih.gov/articles/PMC12753158/
For educational and research purposes only. Not medical advice. Not for human use.
Have a question about TB-500 vs Thymosin Beta-4 — Fragment vs Full Protein? Send us an email →